C9769 HCPCS Prostatic Stent Reimbursement | OpenPayer

Summary & Overview

HCPCS C9769: Cystourethroscopy with Temporary Prostatic Implant/Stent

HCPCS Level II code C9769 represents cystourethroscopy with insertion of a temporary prostatic implant or stent including fixation/anchor and incisional struts. The code captures an endoscopic, device-based intervention for prostatic obstruction delivered in procedural settings and is relevant to urology procedural coding, device coverage, and outpatient surgical reimbursement. Nationally, accurate coding for procedures such as C9769 affects claims adjudication, coverage determinations for temporary prostatic implants, and reporting of procedural utilization.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, common payer policies that influence coverage decisions, typical sites of service, and common modifiers used with procedural billing. The publication also outlines benchmarking considerations and coding practice implications for clinicians and billing professionals who manage endoscopic prostatic device placements.

This summary is intended for a national audience and focuses on the code definition, clinical setting, and the payer landscape. Data not available in the input will be noted where applicable in the full publication.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareC9769HCPCS Level IIurologycystourethroscopyprostatic stentoutpatient surgeryprocedural codingmedical billing

Billing Code Overview

HCPCS Level II code C9769 describes a cystourethroscopy with insertion of a temporary prostatic implant or stent that includes fixation/anchor and incisional struts. This procedure involves endoscopic visualization of the bladder and urethra to place a temporary prostatic device intended to relieve obstructive symptoms related to the prostate.

Service type: Endoscopic surgical/procedural implantation of a temporary prostatic stent/implant

Typical site of service: Hospital outpatient department or ambulatory surgery center, depending on clinical setting and facility capabilities.

Clinical & Coding Specifications

Clinical Context

A typical patient is a male in his 60s–80s with symptomatic benign prostatic hyperplasia (BPH) causing lower urinary tract symptoms (LUTS), recurrent urinary retention, recurrent urinary tract infections, or urethral obstruction. The patient has failed or is intolerant of medical therapy (alpha blockers, 5-alpha-reductase inhibitors) or has anatomic features that make temporary prostatic stent placement appropriate. Pre-procedure evaluation includes history and physical, urinalysis/urine culture, prostate imaging or transrectal ultrasound as indicated, anticoagulation review, and informed consent that the device is temporary and may require removal.

Procedure workflow: The patient is brought to an ambulatory surgery center or hospital outpatient department after peri-procedural clearance. Under local, monitored anesthesia care, or general anesthesia depending on patient comorbidity and provider preference, cystourethroscopy is performed to visualize the urethra and prostatic urethra. A temporary prostatic implant/stent with fixation/anchor and incisional struts is inserted under direct cystoscopic visualization and positioned to span prostatic obstruction, restoring urine flow while allowing drainage and minimizing irritation. The implant is anchored to prevent migration. Post-placement, urinary flow is assessed, and the patient is monitored in recovery for voiding, hematuria, pain control, and urinary retention. Follow-up includes device checks, possible imaging or cystoscopy, and scheduled removal or exchange per device instructions or clinical need.

Coding Specifications

Modifier	Description	When to Use
`22`

HCPCS C1740: Leadless Electrode and Battery for Left Ventricular Pacing

HCPCS-C9069-BELANTAMAB-MAFODONTIN-INJECTION-0-5-MG

HCPCS Level II C9069: Injection, belantamab mafodontin-blmf, 0.5 mg

HCPCS-C1822-IMPLANTABLE-HIGH-FREQUENCY-NEUROSTIMULATOR-RECHARGEABLE

HCPCS C1822: Implantable High-Frequency Neurostimulator with Rechargeable Battery

HCPCS-C9778-VAGINAL-COLPOPEXY-SACROSPINOUS-MINIMALLY-INVASIVE

HCPCS C9778: Vaginal Colpopexy, Minimally Invasive Sacrospinous Approach

HCPCS-C8905-BREAST-MRI-WITHOUT-THEN-WITH-CONTRAST-UNILATERAL

HCPCS C8905: Unilateral Breast MRI Without then With Contrast

HCPCS-C1782-MORCELLATOR-SURGICAL-INSTRUMENT

HCPCS Level II C1782: Morcellator, Surgical Instrument

HCPCS-C1759-INTRACARDIAC-ECHOCARDIOGRAPHY-CATHETER

HCPCS C1759: Intracardiac Echocardiography Catheter

HCPCS-C1748-SINGLE-USE-UPPER-GI-ENDOSCOPE-IMAGING

HCPCS C1748: Single-Use Upper GI Endoscope, Imaging/Illumination

HCPCS-C1832-AUTOGRAFT-SUSPENSION-CELL-PROCESSING-APPLICATION

HCPCS C1832: Autograft Suspension with Cell Processing and Application

HCPCS-C2642-CESIUM-131-BRACHYTHERAPY-SOURCE-STRANDED

HCPCS C2642: Brachytherapy Source, Cesium-131, Stranded

Showing 1–10 of 603

Taxonomy Code	Specialty	Notes
`208000000X`	Urology	Primary specialty that performs cystourethroscopy and prostatic stent placement.
`207L00000X`	Female Pelvic Medicine & Reconstructive Surgery	May perform endoscopic prostatic/urethral procedures in specialized practices (less common for male prostatic stent).
`208800000X`	Interventional Urology	Subspecialty focus on endoscopic implants and device-based treatments.
`363L00000X`	Anesthesiology	Provides anesthesia services for the procedure in OR or ASC settings.
`207K00000X`	General Surgery	Occasionally involved in complex cases or multidisciplinary settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N40.0`	Enlarged prostate with lower urinary tract symptoms	Primary indication for temporary prostatic stent placement to relieve obstruction.
`N13.8`	Other obstructive and reflux uropathy	Prostatic obstruction causing upstream effects may prompt stent use.
`N39.0`	Urinary tract infection, site not specified	Recurrent UTIs related to urinary stasis from prostatic obstruction; stent may be used to improve drainage.
`R33.9`	Retention of urine, unspecified	Acute or chronic urinary retention is an indication for temporary prostatic stenting when catheterization or surgery is unsuitable.
`N32.0`	Bladder-neck obstruction	Functional or anatomic obstruction at bladder neck that may be addressed by a stent spanning the prostatic urethra.
`R33.8`	Other retention of urine	Includes specific retention etiologies where temporary stent can restore voiding.
`R39.15`	Urgency of urination	Severe LUTS including urgency often coexist with obstructive symptoms treated with stent therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`52000`	Cystourethroscopy, with catheterization and/or injection, simple; diagnostic (separate procedure)	Diagnostic cystourethroscopy may be performed immediately before stent placement to evaluate anatomy and plan device insertion.
`52005`	Cystourethroscopy, with ureteral catheterization, with or without irrigation, diagnostic	May be used if additional access or irrigation is required during evaluation prior to stent insertion.
`52601`	Transurethral electrosurgical resection of prostate, any method, single or multiple fragments, including control of postoperative bleeding, complete	Alternative definitive surgical therapy for BPH; may be performed instead of or following temporary stent therapy.
`53410`	Prostatectomy, transurethral, thermal resection or ablation of prostate; single session	Represents other endoscopic options for obstructive BPH that may be performed before or after consideration of temporary stent placement.
`54050`	Removal of foreign body, urethra; with instrument (separate procedure)	Used if stent removal is required in a subsequent procedure or if stent migration necessitates endoscopic retrieval.

OpenPayer